Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH1 mutation-associated long non-coding RNA expression profile changes in glioma.

Journal of neuro-oncology - 1 Nov 2015

Zhang Xiao-Qin, Kiang Karrie Mei-Yee, Wang Yue-Chun, Pu Jenny Kan-Suen, Ho Amy, Cheng Stephen Yin, Lee Derek, Zhang Ping-De, Chen Jia-Jing, Lui Wai-Man, Fung Ching-Fai, Leung Gilberto Ka-Kit

Abstract excerpt

Isocitrate dehydrogenase 1 (IDH1) mutation is an important prognostic marker in glioma. However, its downstream effect remains incompletely understood. Long non-coding RNAs (lncRNAs) are emerging as important regulators of tumorigenesis in a number of human malignancies, including glioma. Here, we investigated whether and how lncRNA expression profiles would differ between gliomas with or without IDH1 mutation....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Databases, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Oligonucleotide Array Sequence Analysis

Share to RNA, Long Noncoding

Share to Statistics, Nonparametric

Share to Survival Analysis

Source

Identifiers

PMID: 26337623
DOI: 10.1007/s11060-015-1916-9

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH1 mutation-associated long non-coding RNA expression profile changes in glioma.PMID 26337623Read ↗

Long non-coding RNA in glioma: novel genetic players in temozolomide resistanceSemantic proximity Read ↗

Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.Semantic proximity Read ↗

Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.Semantic proximity Read ↗

From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma.Semantic proximity Read ↗

lncRNA TRHDE-AS1 correlated with genomic landscape and clinical outcome in gliomaSemantic proximity Read ↗

Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.Semantic proximity Read ↗

Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art ReviewSemantic proximity Read ↗

Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas.Semantic proximity Read ↗

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.Semantic proximity Read ↗

Long non-coding RNA expression profiles predict clinical phenotypes in glioma.Semantic proximity Read ↗

Identification of a three-long non-coding RNA signature for predicting survival of temozolomide-treated isocitrate dehydrogenase mutant low-grade gliomas.Semantic proximity Read ↗

Unraveling the tumor-promoting role of wildtype Isocitrate dehydrogenase 1 (IDH1) in human gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.